About Rini Life Science
Rini Life Science is a Healthcare company based in Indore (India) founded in 2004. It specializes as a CDMO focused on manufacturing active pharmaceutical ingredients. It operates on a B2B model. The company has 59 employees. Its Indian entity Rini Life Science Private Limited reported revenue of ₹57.30 Cr. Its focus areas include Pharmaceuticals, Manufacturing, CDMO Services and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Rini Life Science, established in 2004, excels in producing pharmaceutical products, producing manufactured goods, cdmo services, and api production. Specializes as a CDMO focused on manufacturing active pharmaceutical ingredients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Indore, India
- Employees 59
- SectorsHealthcare
- Email••••••••
- Website rinilifescience.com
- Legal Name Rini Life Science Private Limited
- Date of Incorporation 03 Feb, 2004
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹57.30 Cr
FY 2025 · +8% YoY
- Net Profit₹1.52 Cr
FY 2025 · 3% margin
- EBITDA₹3.67 Cr
FY 2025 · 6% margin
- Employee Count59
Associated legal entities of Rini Life Science
Rini Life Science operates through Rini Life Science Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rini Life Science Private Limited CIN U51101MP2004PTC016376 | Active | 03 Feb 2004 | Indore, Madhya Pradesh | ₹57.3 Cr | 59 | 3 | View details |
Board of directors of Rini Life Science Private Limited (Rini Life Science)
Rini Life Science Private Limited is the primary company behind Rini Life Science. The board of Rini Life Science Private Limited currently have 3 directors; the longest-serving is Rajnish Chordia, appointed in 2004. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajnish Chordia DIN 00451139 | Whole-time director | 03 Feb 2004 | 22 yrs 8 mo | Rini Life Science Private Limited |
| Rakesh Kumar Chordia DIN 00451391 | Whole-time director | 03 Feb 2004 | 22 yrs 8 mo | Rini Life Science Private Limited |
| Gopal DIN 08626303 | Director | 30 Nov 2019 | 6 yrs 10 mo | Rini Life Science Private Limited |
Financials of Rini Life Science
Figures of Rini Life Science Private Limited, the primary company behind Rini Life Science, for FY 2025. Revenue was ₹57.30 Cr (+8% year on year). Net profit was ₹1.52 Cr (3% margin). EBITDA was ₹3.67 Cr (6% margin). Revenue has grown at a compounded annual rate of +13% over three years and +8% over five years.
- ₹57.30 CrRevenue · FY 2025 · +8% YoY
- ₹1.52 CrNet profit · 3% margin
- ₹3.67 CrEBITDA · 6% margin
- ₹11.4 LakhPaid-up capital
- 59Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rini Life Science Private Limited are on its company page.
Detailed financial statements for Rini Life Science
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Rini Life Science
Rini Life Science has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Rini Life Science
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rini Life Science
Rini Life Science was founded in 2004.
Rini Life Science is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Rini Life Science has 59 employees.
The primary company behind Rini Life Science, Rini Life Science Private Limited, reported revenue of ₹57.30 Cr for FY 2025, up 8% year on year.
Rini Life Science, established in 2004, excels in producing pharmaceutical products, producing manufactured goods, cdmo services, and api production. Specializes as a CDMO focused on manufacturing active pharmaceutical ingredients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Rini Life Science's top competitors include Laurus Labs, Symbiotec and SeQuent.
Rini Life Science operates through Rini Life Science Private Limited.
The legal entities of Rini Life Science currently have 3 directors, including Rajnish Chordia, Rakesh Kumar Chordia, Gopal.